Posted on

cbd capsules for sexual dysfunction

From the perspective of treating ED-related anxiety, CBD-rich oil may be helpful, according to some experts.

For these men, there is hope in the form of prescription medications or psychotherapy, depending on the root cause. Weedmaps News recently reported that cannabidiol (CBD) may enhance sex, making it more satisfying and less painful for both partners. Could CBD oil, specifically CBD-rich cannabis oil, which retains other cannabinoids and terpenes, offer similar benefits for men with ED?

The CBD/THCV combination could indirectly help men with ED by decreasing appetite and, potentially, contributing to weight loss. Based on this evidence, a broad-spectrum product which contains both of these beneficial cannabinoids could be useful. Cannabis product labels should list which cannabinoids are included and in what concentrations. Only lab-verified products are guaranteed to be pure.

What the experts say

A greater amount of research exists for managing the psychological symptoms of erectile dysfunction than the physiological ones. In particular, CBD oil has shown to be effective in decreasing anxiety in a number of studies. While most studies utilized CBD oil that was either broad-spectrum or full-spectrum, CBD isolates (products that lack THC and other compounds), may also provide beneficial effects. Because CBD is such a significant part of the cannabis plant, cannabis itself could play an important role in alleviating ED.

The potential benefits of CBD could be ideal for men who do not want to take medications long term but would prefer to treat their ED situationally. Photo by: Gina Coleman/Weedmaps

Obesity is one physical cause of erectile dysfunction that CBD could potentially treat, although CBD on its own was nowhere near as effective as CBD paired with tetrahydrocannabivarin (THCV) in the supporting study. In 2012, the British newspaper The Daily Telegraph published an article titled, “Cannabis Could Be Used to Treat Obesity-Related Diseases.” Science correspondent Richard Gray wrote about the revealing study conducted by GW Pharmaceuticals: “When the scientists examined two compounds, called THCV and cannabidiol, they were found to have an appetite-suppressing effect.”

Commonly referred to as ED, erectile dysfunction affects 30 million American men of all ages. The causes of erectile dysfunction may be physiological, psychological, or a combination of both. Certain men may be at greater risk of developing erectile dysfunction, such as those who are older than 50, are overweight, or have heart disease.

Guimaraes VM, Zuardi AW, Del Bel EA, Guimaraes FS. Cannabidiol increases Fos expression in the nucleus accumbens but not in the dorsal striatum. Life Sci 2004;75(5):633-8. View abstract.

Bisogno T, Di Marzo Y. The role of the endocannabinoid system in Alzheimer’s disease: facts and hypotheses. Curr Pharm Des 2008;14(23):2299-3305. View abstract.

Laux LC, Bebin EM, Checketts D, et al. Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results. Epilepsy Res. 2019;154:13-20. View abstract.

Insufficient Evidence for

Arkell TR, Vinckenbosch F, Kevin RC, Theunissen EL, McGregor IS, Ramaekers JG. Effect of Cannabidiol and ?9-Tetrahydrocannabinol on Driving Performance: A Randomized Clinical Trial. JAMA. 2020;324(21):2177-2186. View abstract.

Arkell TR, Lintzeris N, Kevin RC, et al. Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition. Psychopharmacology (Berl). 2019;236(9):2713-2724. View abstract.

Esposito G, Scuderi C, Savani C, et al. Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression. Br J Pharmacol 2007;151(8):1272-9. View abstract.

Pertwee RG. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delat9-tetrahydrocannabivarin. Br J Pharmacol 2008;153:199-215. View abstract.